MOUNT SINAI SCHOOL OF MEDICINE TO BE NAMED IN HONOR OF ICAHN
(The following press release from Mount Sinai Medical Center was received by e-mail. The sender verified the statement.)
MOUNT SINAI SCHOOL OF MEDICINE TO BE NAMED IN HONOR OF CARL ICAHN
Newest Gift to Mount Sinai Caps Nearly $200 Million in Lifetime Support
(New York – November 15, 2012) – Mount Sinai President and CEO Kenneth L. Davis, MD and Chairman of the Boards of Trustees Peter W. May announced today that the Mount Sinai School of Medicine has been renamed the Icahn School of Medicine at Mount Sinai in honor of Trustee Carl C. Icahn. Mr. Icahn, whose latest gift is the largest in Mount Sinai’s history and among the biggest ever given to a medical school, signed the formal agreement Tuesday, November 13, 2012 at his offices in midtown Manhattan.
The new name was approved by the Boards of Trustees on September 24 in recognition of Mr. Icahn’s many years of dedicated service to the institution, his leadership in advancing medical science, and his nearly $200 million in lifetime giving to Mount Sinai. In addition, the Institute for Genomics and Multiscale Biology will be renamed the Icahn Genomics Institute.
“Carl’s support enables our scientists and clinicians to continue pursuing groundbreaking discoveries. We are honored to bear the Icahn School of Medicine name as we revolutionize healthcare for Mount Sinai patients and for patients around the world,” said Dr. Davis.
Mr. Icahn, one of America’s most prominent and influential investors, has been a member of the Boards of Trustees, and a Trustee of the School of Medicine since 2000. His gifts have been, and will continue to be, utilized for general medical research as well as specific research in the burgeoning field of genomics in order to improve the diagnosis and treatment of disease.
Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine and Executive Vice President for Academic Affairs of The Mount Sinai Medical Center, said Mr. Icahn’s remarkable generosity would fund various research projects at the medical school’s numerous disease-focused and core technology-based institutes, including the newly named Icahn Institute for Genomics.
“Carl Icahn’s generosity has tremendously strengthened Mount Sinai’s capacity for innovation by allowing us flexibility and opportunistic creativity, two of the greatest assets for any innovative organization,” said Dr. Charney. “We are extremely grateful to Carl not only for his philanthropic support but also for his trust and confidence in Mount Sinai and the major role our institution will continue to play in transforming global health care.”
Mr. Icahn’s previous contributions to Mount Sinai resulted in a state-of-the-art medical school research building on the Mount Sinai campus being named The Icahn Medical Institute.
“I have been very impressed with Mount Sinai’s extraordinary achievements to date in scientific discovery, medical education, translational medicine and patient care,” said Mr. Icahn. “I am certain that my contributions to Mount Sinai will lead to significant medical breakthroughs in the diagnosis and treatment of disease that will dramatically improve and extend human life.”
Mr. Icahn’s most recent giving to Mount Sinai has supported the Campaign for Mount Sinai, a $1 billion capital campaign that launched in 2008 and that recently surpassed its target, well in advance of its scheduled December 2013 conclusion. “Carl Icahn has been a remarkable supporter of the capital campaign, and as a philanthropist, he is a game-changer for Mount Sinai,” said Peter May. “His gift helped us to surpass our original $1 billion goal and has given us the momentum we need to reach our new goal of $1.3 billion.”
“No matter how you look at it, this is a historic time for Mount Sinai,” said Trustee James S. Tisch, who is chairman of the Campaign for Mount Sinai. “Carl’s gift caps off one of the most generous outpourings of institutional support I have ever seen. And with a year to go, every gift we receive ensures that more and more advances will be made in the research and clinical care that are the hallmarks of Mount Sinai.”
About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School of Medicine at Mount Sinai is one of the leading medical schools in the United States. The Icahn School of Medicine is noted for innovation in education, biomedical research, clinical care delivery, and local and global community service. It has more than 3,400 faculty members in 32 departments and 14 research institutes, and ranks among the top 20 medical schools both in National Institutes of Health (NIH) funding and by U.S. News & World Report.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked The Mount Sinai Hospital 14th on its elite Honor Roll of the nation’s top hospitals based on reputation, safety, and other patient-care factors. Mount Sinai is one of just 12 integrated academic medical centers whose medical school ranks among the top 20 in NIH funding and by U.S. News & World Report and whose hospital is on the U.S. News & World Report Honor Roll. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 560,000 outpatient visits took place.
Contact: Mount Sinai Medical Center Newsroom 212-241-9200 NewsMedia@mssm.edu